One of the main motivations for screening for diabetic retinopathy is the long-established efficacy of laser photocoagulation surgery in preventing visual loss. Two large trials, the Diabetic ...

Treating diabetic retinopathy (DR) is still a significant challenge for clinicians and remains a leading cause of blindness worldwide. NovaGo Therapeutics is developing a human antibody therapy ...

Although laser photocoagulation is an effective treatment for proliferative diabetic retinopathy, few options were available at that time for wet AMD (Box 1). Visual acuity tests are the most ...

As a retina specialist, one of the most important aspects of eye care I focus on is the prevention and treatment of diabetic retinopathy. This condition is a leading cause of blindness in adults, yet ...

It offers an alternative to current treatment of diabetic retinopathy using laser photocoagulation therapy, steroid implants or injections of anti-VEGF drugs like Bayer/Regeneron's Eylea ...

The FDA has approved Susvimo (ranibizumab injection) for the treatment of patients with diabetic macular edema.

Diabetic retinopathy (DR) is an important cause of avoidable blindness worldwide. Seventy percent of diabetes occur in low and lower-middle income countries. Clinical practice guidelines for the ...

photocoagulation, laser treatment, and vitrectomy, depending upon the severity of the condition. When it comes to diabetic ...

Data from various retinal clinical trials suggest that there is a difference in efficacy in anti-VEGF therapies for patients ...

effectiveness and acceptability of anti-VEGFs and laser photocoagulation (alone or in combination) for the treatment of non-proliferative and proliferative diabetic retinopathy.